Psoriasis: all 1,928 studies
Page 19 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.
- Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type PsoriasisCompletedNCT00539929Phase 2
- Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light TherapyCompletedNCT00537212Not applicable
- Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical TrialCompletedNCT00512187Phase 4
- Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving EfalizumabCompletedNCT00510536Phase 4
- Psoriasis Longitudinal Assessment and RegistryActive, not recruitingNCT00508547
- A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.CompletedNCT00504270Phase 2
- Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque PsoriasisCompletedNCT00493324Phase 4
- A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545CompletedNCT00472758Phase 1
- Assessment and Tracking of Long-term Alefacept SafetyTerminatedNCT00454701
- Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug TreatmentCompletedNCT00451243
- AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis SubjectsCompletedNCT00443326Phase 2
- Efalizumab for Treatment of Patients With Moderate to Severe PsoriasisCompletedNCT00442650Phase 3
- A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.CompletedNCT00437619Phase 4
- Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in PsoriasisCompletedNCT00437255Phase 4
- Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque PsoriasisCompletedNCT00437216
- A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) FoamCompletedNCT00436540Phase 4
- Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical MedicationsTerminatedNCT00427609Phase 2
- Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan PatientsCompletedNCT00422617Not applicable
- Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.CompletedNCT00417820Phase 1
- Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis PatientsCompletedNCT00408187Phase 3
- Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and PsoriasisCompletedNCT00407979
- Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis.CompletedNCT00407342Not applicable
- RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment OptimizationTerminatedNCT00402818
- A Study of BMS-582949 in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT00399906Phase 2
- Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque PsoriasisCompletedNCT00396422Phase 2
- Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With PsoriasisCompletedNCT00395941Phase 2
- Safety and Efficacy of Topically Applied CTA018 in Plaque PsoriasisCompletedNCT00384098Phase 2
- A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque PsoriasisCompletedNCT00382512Phase 1
- The Effectiveness of Lower Cyclosporine Doses for PsoriasisWithdrawnNCT00377325Phase 2
- Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type PsoriasisCompletedNCT00373516Phase 2
- Effect of Atopic Diathesis as Assessed by Serum Th1/Th2 Cytokine Profile on Clinical Manifestation of PsoriasisStatus unknownNCT00372580
- Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) ProgramCompletedNCT00371774
- Molecular and Cellular Characterization of Spongiotic DermatitisCompletedNCT00371163
- T Cell Repertoire Analysis of Immune Mediated Skin DiseasesCompletedNCT00368784
- Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis VulgarisStatus unknownNCT00365625
- Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034CompletedNCT00358384Phase 1
- Topical Vitamin B12 in Chronic Plaque PsoriasisCompletedNCT00350116Phase 3
- Genetic Analysis of Psoriasis and Psoriatic ArthritisCompletedNCT00341809
- Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00338754Phase 2/3
- A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic TherapiesCompletedNCT00338143Phase 3
- Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe PsoriasisCompletedNCT00333411Phase 2
- Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With PsoriasisCompletedNCT00333034Phase 3
- Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and PsoriasisCompletedNCT00317499Phase 3
- A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or FeetCompletedNCT00312026Phase 4
- Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis VulgarisCompletedNCT00306878Phase 1
- A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe PsoriasisCompletedNCT00302445Phase 4
- Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar PustulosisCompletedNCT00301002Phase 2
- CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.Status unknownNCT00295425Phase 2
- A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293930Phase 3
- A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293917Phase 3
- A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293891Phase 3
- Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00292396Phase 2
- Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis VulgarisCompletedNCT00287547Phase 2
- Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in PsoriasisCompletedNCT00279162Phase 3
- A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis VulgarisCompletedNCT00277225Phase 1
- Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis VulgarisCompletedNCT00263718Phase 2
- A Long-term Safety Study of Infliximab (Remicade)CompletedNCT00261976
- A 36-Week Extension to Protocol ISA04-03CompletedNCT00258713Phase 3
- CLEAR Study: Clinical Experience Acquired With Raptiva StudyCompletedNCT00256139Phase 3
- Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp PsoriasisCompletedNCT00243464Phase 3
- Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00237887Phase 3
- Evaluation of Topical Antipsoriatics in the Psoriasis Plaque TestCompletedNCT00236171Not applicable
- Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe PsoriasisCompletedNCT00236119Phase 2
- Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00235820Phase 3
- Curcuminoids for the Treatment of Chronic Psoriasis VulgarisCompletedNCT00235625Phase 2
- Study of a New Dressing for Use With Topical MedicationsCompletedNCT00234728Not applicable
- Safety and Tolerability of Repeat Courses of IM AlefaceptCompletedNCT00233662Phase 3
- A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type PsoriasisCompletedNCT00230529Phase 2
- Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque PsoriasisCompletedNCT00227240
- The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a AntagonistsStatus unknownNCT00224562
- Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris.CompletedNCT00220025Phase 1
- Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases.TerminatedNCT00217009Early Phase 1
- Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis VulgarisCompletedNCT00216892Phase 4
- Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp PsoriasisCompletedNCT00216879Phase 3
- Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp PsoriasisCompletedNCT00216840Phase 3
- Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp PsoriasisCompletedNCT00216827Phase 3
- Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765CompletedNCT00205465Phase 2
- Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque PsoriasisCompletedNCT00192517Phase 2
- Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque PsoriasisCompletedNCT00192452Phase 2
- Classification and Characterization of Patients Treated With Efalizumab for Plaque PsoriasisTerminatedNCT00184366
- Community Based Trial for AMEVIVE®CompletedNCT00168753Phase 4
- Psychiatric Problems in Chronic Skin DiseasesCompletedNCT00167752
- Role of CD7 in Skin Inflammation and PsoriasisCompletedNCT00162825
- Study of BMS-587101 in Patients With Moderate to Severe PsoriasisTerminatedNCT00162253Phase 2
- Study Evaluating Etanercept and Methotrexate in Plaque PsoriasisCompletedNCT00161655Phase 4
- Bexarotene With Narrow-Band UVB for PsoriasisCompletedNCT00151008Phase 2
- Alefacept Mechanism of Action in PsoriasisCompletedNCT00150982Phase 2
- Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-EffectivenessStatus unknownNCT00150930Phase 4
- Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque PsoriasisCompletedNCT00147329Phase 2
- Transitioning From Cyclosporine to Alefacept in PsoriasisCompletedNCT00143806Phase 2
- Etanercept With Tacrolimus for PsoriasisCompletedNCT00134394Phase 2
- Long-Term Follow-Up Study of Psoriasis PatientsCompletedNCT00131066
- Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin ConditionsTerminatedNCT00129415Phase 1/2
- Study of Etanercept in the Treatment of Psoriasis in Adult SubjectsCompletedNCT00121615Phase 3
- Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With PsoriasisCompletedNCT00116181Phase 3
- A Study of Tetrathiomolybdate in the Treatment of Psoriasis VulgarisCompletedNCT00113542Phase 2
- Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With PsoriasisCompletedNCT00111449Phase 3
- Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult SubjectsCompletedNCT00111436Phase 3
- Enbrel® in Psoriatic ArthritisCompletedNCT00111124Phase 4
- An Evaluation of Etanercept in the Treatment of Subjects With PsoriasisCompletedNCT00111111Phase 3